OS Therapies Inc
Developing a cancer vaccine to treat HER2-expressing tumors, primarily Osteosarcoma.
OSTX | US
Overview
Corporate Details
- ISIN(s):
- US68764Y2072
- LEI:
- Country:
- United States of America
- Address:
- 15825 SHADY GROVE ROAD, 20850 ROCKVILLE
- Website:
- https://ostherapies.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
OS Therapies Inc. is a clinical-stage immunotherapy company focused on the development and commercialization of treatments for cancer. The company develops therapies designed to activate the patient's immune system to target and kill cancers expressing the HER2 protein. Its lead candidate, OST-HER2, is a cancer vaccine primarily targeting Osteosarcoma, a type of bone cancer with a significant unmet medical need in both pediatric and adult patients. OS Therapies is also planning to expand its therapeutic development into other HER2-expressing solid tumors, including breast, colorectal, esophageal, lung, and ovarian cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all OS Therapies Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OS Therapies Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OS Therapies Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
